UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort

The Journal of infection, 2021-03, Vol.82 (3), p.384-390

2021

Volltextzugriff (PDF)

The impact of the M184V substitution in HIV‐1 reverse transcriptase on treatment response

HIV medicine, 2002-04, Vol.3 (2), p.135-145

2002

Volltextzugriff (PDF)

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

The New England journal of medicine, 2008-11, Vol.359 (21), p.2233-2244

2008

Volltextzugriff (PDF)

The abacavir hypersensitivity reaction and interruptions in therapy

AIDS (London), 2001-07, Vol.15 (10), p.1325-1325

2001

Volltextzugriff (PDF)

The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study

Annals of neurology, 1984-11, Vol.16 (5), p.553-558

1984

Volltextzugriff (PDF)

Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons

AIDS research and human retroviruses, 1998-08, Vol.14 (12), p.1053-1058

1998

Volltextzugriff (PDF)

Therapeutic target values in oral anticoagulation : justification of Dutch policy and a warning against to so-called moderate-intensity regimens

Annals of hematology, 1992-02, Vol.64 (2), p.60-65

LOELIGER, E. A

1992

Volltextzugriff (PDF)

International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control

Thrombosis and haemostasis, 1985-01, Vol.53 (1), p.155-156

Loeliger, E A

1985

Volltextzugriff (PDF)

Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively

The Journal of clinical investigation, 1997-11, Vol.100 (9), p.2325-2332

1997

Volltextzugriff (PDF)

Cardiogenic embolism to the brain

The Lancet (British edition), 1992-04, Vol.339 (8797), p.877-877

Loeliger, E.A.

1992

Volltextzugriff (PDF)

Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control

Thrombosis and haemostasis, 1985-01, Vol.53 (1), p.148-154

1985

Volltextzugriff (PDF)

Oral Anticoagulant Therapy Recommendations

Chest, 1994-01, Vol.105 (1), p.327-328

Loeliger, Emil A.

1994

Volltextzugriff (PDF)

Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments

AIDS (London), 1993-11, Vol.7, p.S15-S20

1993

Volltextzugriff (PDF)

Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation

Acta haematologica, 1985-01, Vol.74 (3), p.125-131

Loeliger, E A

1985

Volltextzugriff (PDF)

Questions and answers on prothrombin time standardisation in oral anticoagulant control

Thrombosis and haemostasis, 1985-01, Vol.54 (2), p.515-517

1985

Volltextzugriff (PDF)

The optimal therapeutic range in oral anticoagulation. History and proposal

Thrombosis and haemostasis, 1979-01, Vol.42 (4), p.1141-1152

Loeliger, E A

1979

Volltextzugriff (PDF)

Protein C and the development of skin necrosis during anticoagulant therapy

Thrombosis and haemostasis, 1983-01, Vol.49 (3), p.251-251

1983

Volltextzugriff (PDF)

Oral anticoagulation in patients surviving myocardial infarction: a new approach to old data

European journal of clinical pharmacology, 1984, Vol.26 (1), p.137-139

LOELIGER, E. A

1984

Volltextzugriff (PDF)

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis

The American journal of medicine, 1995-08, Vol.99 (2), p.225-225

Loeliger, E.A.

1995

Volltextzugriff (PDF)

Does dipyridamole have antithrombotic potential?

Thrombosis and haemostasis, 1985-01, Vol.53 (3), p.437-437

Loeliger, E A

1985

Volltextzugriff (PDF)

A collaborative calibration study of reference materials for thromboplastins

Thrombosis and haemostasis, 1983-01, Vol.50 (3), p.712-717

1983

Volltextzugriff (PDF)

Long‐term stability of international reference preparations for thromboplastins

British journal of haematology, 1988-03, Vol.68 (3), p.321-328

1988

Volltextzugriff (PDF)

Deficient antipneumococcal polysaccharide responses in HIV‐seropositive patients

FEMS immunology and medical microbiology, 1995-09, Vol.12 (1), p.33-41

1995

Volltextzugriff (PDF)

Anticoagulant therapy in acute myocardial infarction

The American heart journal, 1985-12, Vol.110 (6), p.1322-1323

Loeliger, E.A.

1985

Volltextzugriff (PDF)

Oral anticoagulation versus aspirin after myocardial infarction

The New England journal of medicine, 1983-02, Vol.308 (5), p.282-282

Loeliger, E A

1983

Volltextzugriff (PDF)

1 – 25 von 456

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(233)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(227)
Science & Technology
(195)
Life Sciences & Biomedicine
(148)
Physics
(78)
Female
(59)
Physics And Astronomy
(59)
Elementary Particles
(58)
Quantum Field Theories
(58)
Quantum Field Theory
(58)
String Theory
(58)
Male
(55)
Protons
(55)
Regular Article - Experimental Physics
(53)
Luminosity
(51)
Particle Collisions
(51)
Physical Sciences
(44)
Prothrombin Time
(44)
Biological And Medical Sciences
(43)
Anticoagulants - Therapeutic Use
(42)
Large Hadron Collider
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort

The impact of the M184V substitution in HIV‐1 reverse transcriptase on treatment response

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

The abacavir hypersensitivity reaction and interruptions in therapy

The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study

Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons

Therapeutic target values in oral anticoagulation : justification of Dutch policy and a warning against to so-called moderate-intensity regimens

International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control

Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively

Cardiogenic embolism to the brain

Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control

Oral Anticoagulant Therapy Recommendations

Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments

Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation

Questions and answers on prothrombin time standardisation in oral anticoagulant control

The optimal therapeutic range in oral anticoagulation. History and proposal

Protein C and the development of skin necrosis during anticoagulant therapy

Oral anticoagulation in patients surviving myocardial infarction: a new approach to old data

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis

Does dipyridamole have antithrombotic potential?

A collaborative calibration study of reference materials for thromboplastins

Long‐term stability of international reference preparations for thromboplastins

Deficient antipneumococcal polysaccharide responses in HIV‐seropositive patients

Anticoagulant therapy in acute myocardial infarction

Oral anticoagulation versus aspirin after myocardial infarction

Suchergebnisse filtern